Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis.

Dieuwke Luijten Delphine Douillet Kim Luijken Cécile Tromeur Andrea Penaloza Olivier Hugli Drahomir Aujesky Alexandru Grigorean Joseph R BledsoeKyle E ChangFrancis Couturaud Paul L den Exter Carme Font Menno V HuismanDavid JimenezChristopher KabrhelJeffrey A KlineStavros V Konstantinides Thijs E van Mens Remedios OteroW Frank PeacockOlivier Sanchez William B Stubblefield Luca Valerio David R VinsonPhilip WellsMaarten van Smeden Pierre-Marie Roy Frederikus Albertus Klok

Published in: European heart journal (2024)

The incidence of adverse events in home-treated PE patients, selected by a validated triage tool, was very low. Patients with cancer had a three- to five-fold higher incidence of adverse events and death. Patients with increased troponin or (NT-pro)BNP had a three-fold higher risk of adverse events, driven by recurrent venous thromboembolism and bleeding.

Keyphrases

pulmonary embolism
venous thromboembolism
systematic review
end stage renal disease
newly diagnosed
risk factors
ejection fraction
inferior vena cava
emergency department
chronic kidney disease
healthcare
liver failure
case report
direct oral anticoagulants
atrial fibrillation
drug induced
patient reported